Skip to main content
Industry News
Drugmakers working on powerful, targeted cancer treatments

AstraZeneca, GlaxoSmithKline and other drugmakers have 89 antibody-drug conjugates for cancer in their pipelines. The therapies are designed to release cytotoxins directly into tumors and are up to 10,000 times as potent as standard chemotherapy but do minimal damage to healthy tissue.

Full Story: